---
document_datetime: 2023-09-21 17:15:07
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/osigraft-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: osigraft-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 2.036728
conversion_datetime: 2025-12-23 06:29:12.738837
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Steps taken after granting the Marketing Authorisation

Subsequent post Marketing Authorisation applications agreed upon are summarised in the table below:

For procedures finalised after 1 October 2004 please refer to module 8B.

| Scope                                                                                                                                                                                                                 | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amended on   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|-----------------------------------------|
| Change in container shape                                                                                                                                                                                             | I/0001               | I                        | 02.08.01                            | -                                       |
| Change in test procedure of active substance                                                                                                                                                                          | I/0002               | I/II                     | 26.07.01                            | -                                       |
| Change in specification of excipients in the medicinal product                                                                                                                                                        | I/0003               | I                        | 17.07.01                            | -                                       |
| Change in specification of medicinal product                                                                                                                                                                          | I/0005               | I                        | 02.08.01                            | -                                       |
| Change in specification of excipients in the medicinal product                                                                                                                                                        | I/0006               | I                        | 17.07.01                            | -                                       |
| Change in specification of excipients in the medicinal product                                                                                                                                                        | I/0007               | I                        | 02.08.01                            | - authorised                            |
| Change in test procedure of active substance                                                                                                                                                                          | I/0008               | I(II)                    | 17.01.02                            | -                                       |
| Change to the test method(s) and/or specifications of the finished product. Update of the Summary of Characeteristics (update of the ATC code in the SPC as follows: Bone Morphogenetic Proteins, ATC code: M05BC02). | II/0009              | II                       | 23.01.03                            | 08.04.03                                |
| Change in the name of the medicinal product (either invented name of common name) into Osigraft.                                                                                                                      | I/0010               | I                        | 09.07.02                            | 03.10.02                                |
| Change in test procedure of active substance                                                                                                                                                                          | I/0011               | I(II)                    | 25.07.02                            | -                                       |
| Synthesis or recovery of non-pharmacopoeial excipients in the medicinal products                                                                                                                                      | I/0012               | I                        | 02.08.02                            | -                                       |
| Change in test procedure of active substance                                                                                                                                                                          | I/0013               | I(II)                    | 02.08.02                            | -                                       |
| Extension of shelf-life as foreseen at time of authorisation                                                                                                                                                          | I/0014               | I                        | 17.10.02                            | 12.11.02                                |
| Update of or change(s) to the pharmaceutical documentation                                                                                                                                                            | II/0015              | II                       | 20.11.03                            | -                                       |
| Change in test procedures of the medicinal product Change in test procedures of non-pharmacopoeial excipients                                                                                                         | I/0016               | I                        | 17.11.03                            | -                                       |
| Change(s) to the test method(s) and/or specifications for the finished product                                                                                                                                        | II/0017 longer       | II                       | 24.03.04                            | -                                       |
| Change(s) to the manufacturing process for the finished product                                                                                                                                                       | II/0018              | II                       | 03.06.04                            | -                                       |
| Change(s) to the manufacturing process for the finished product                                                                                                                                                       | II/0019              | II                       | 29.07.04                            | -                                       |
| Change(s) to the test method(s) and/or specifications for the active substance no                                                                                                                                     | II/0020              | II                       | 29.07.04                            | -                                       |
| Update of or change(s) to the pharmaceutical documentation Change(s) to the manufacturing process for the active substance                                                                                            | II/0021              | II                       | 16.09.04                            | -                                       |

1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended for procedures finalised before 01 October 2003. In accordance with Article 6 of Commission Regulation (EC) No 1085/2003 for procedures finalised after 01 October 2003 : I refers to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II application.

Medicinal product no longer authorised

T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 of 7 November 1996.

N refers to a notification in accordance with Article 10(3) of Council Directive 92/27/EEC of 31 March 1992.

2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification date. The Commission Decision will be amended accordingly.